ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

Bill Requires NIH-Funded Researchers To Send Manuscripts To PubMed Central.

November 2, 2007

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Gardasil Approved To Prevent Vulvar And Vaginal Cancers

September 26, 2008

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

In Brief: Hellman Will Leave Harvard To Become Physician In Chief At Memorial. James Awards Announced

April 22, 1983